Pharmaceuticals
Devices maker Stryker mulls $16-bn bid for British peer Smith & Nephew
25 Nov 2014
US medical device maker Stryker Corp is considering structuring the transaction as a tax inversion move, allowing it to move its base to the UK, where the taxes are lower than in the US
US court dumps Ranbaxy’s bid to stall launch of rival generics
20 Nov 2014
Ranbaxy’s move is seen as risky especially since the drug maker has been under regulatory probe for a long period now
Ranbaxy sues US FDA over revoking drug approvals
18 Nov 2014
Generic Nexium and Valcyte together would have contributed about $200 million to Ranbaxy's revenue in the first six months of market exclusivity, say analysts
Actavis in talks to buy US Botox maker Allergan for around $60 billion: report
13 Nov 2014
Last week Allergan had said it was in talks with a suitor, without identifying ithe bidder, which was widely speculated as being Actavis
